首页> 外国专利> Method for Preparing an Immunostimulatory Glycopeptide from Corynebacterium parvum.

Method for Preparing an Immunostimulatory Glycopeptide from Corynebacterium parvum.

机译:从小棒杆菌制备免疫刺激性糖肽的方法。

摘要

1476422 Immunostimulating glycopeptide WELLCOME FOUNDATION Ltd 23 May 1974 [23 Feb 1973 14 Feb 1974] 9149/73 and 6759/74 Heading A5B [Also in Division C3] An immunostimulating glycopeptide capable of conferring on mammals and birds a resistance to tumours and pathogens is obtained from cell wall material of an immunostimulating bacterium of the Actinomycetaceae Family of Prevots classification. Bacteria specified include Corynebacterium parvum, C. anaerobium, C. granulosum, C. liquifaciens, C. pyogenes, C. lymphophilum, C. hepatodystrophicans, C. adamsoni, C. avidium, C. diphtheroides, C. renale cuniculi, C. acnes, C. equi and C. ovis. The glycopeptide is extracted by (a) culturing the bacteria, (b) harvesting the cells and (c) treating the cells with a biphasic extraction solvent comprising water and a phenol so as to yield the glycopeptide as an insoluble residue. The cells are generally subjected to lysis before extraction with the biphasic solvent. The glycopeptide may be recovered by centrifugation. The product is substantially insoluble in water, saline, methanol, ethanol, phenol, chloroform, dioxan, pyridine, dimethylformamide, diethylene glycol and hexane, has infra-red peptide absorption at 1550 and 1660 cmSP-1/SP, infra-red carbohydrate absorption between 950 and 1100 cmSP-1/SP with peak between 1050 and 1070 cmSP-1/SP, has substantially no infra-red lipid absorption between 2850 and 2950 cmSP-1/SP and after intravenous administration increases the liver and spleen weight of mice and increases the life expectancy of mice with tumours. The glycopeptide is combined with a carrier for use.
机译:1476422免疫刺激性糖肽WELLCOME FOUNDATION Ltd 1974年5月23日[1973年2月23日1974年2月14日] 9149/73和6759/74品目A5B [也在C3分部]获得了一种免疫刺激性糖肽,能够赋予哺乳动物和鸟类对肿瘤和病原体的抗性来源于放线菌科的放线菌科的免疫刺激细菌的细胞壁材料。指定的细菌包括小棒杆菌,厌氧梭状芽孢杆菌,颗粒状梭状芽胞杆菌,液态梭状芽孢杆菌,化脓性梭状芽孢杆菌,嗜酸性梭状芽胞杆菌,肝性嗜麦芽疏螺旋菌,假单胞菌亚当森,C。avidium,梭状芽孢杆菌,C。 ,C。equi和C. ovis。通过(a)培养细菌,(b)收获细胞和(c)用包含水和苯酚的双相提取溶剂处理细胞来提取糖肽,从而产生作为不溶性残基的糖肽。通常在用双相溶剂萃取之前将细胞裂解。糖肽可以通过离心回收。该产物基本上不溶于水,盐水,甲醇,乙醇,苯酚,氯仿,二恶烷,吡啶,二甲基甲酰胺,二甘醇和己烷,在1550和1660 cm -1 处具有红外肽吸收,在950和1100 cm -1 之间的红外碳水化合物吸收,在1050和1070 cm -1 之间的峰值,在2850和2950 cm < SP> -1 和静脉给药后会增加小鼠的肝脏和脾脏重量,并增加患有肿瘤的小鼠的预期寿命。糖肽与载体结合使用。

著录项

  • 公开/公告号DK141757B

    专利类型

  • 公开/公告日1980-06-09

    原文格式PDF

  • 申请/专利权人 THE WELLCOME FOUNDATION LIMITED;

    申请/专利号DK19740000961

  • 发明设计人 CHRISTOPHER ADLAM;DAVID ERIC REID;

    申请日1974-02-22

  • 分类号C07G7/00;C12P21/00;A61K39/05;A61K39/39;

  • 国家 DK

  • 入库时间 2022-08-22 18:35:03

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号